Last reviewed · How we verify
Ticagrelor Oral Tablet - Pre-Treatment — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Ticagrelor Oral Tablet - Pre-Treatment (Ticagrelor Oral Tablet - Pre-Treatment) — SFJ Pharmaceuticals, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ticagrelor Oral Tablet - Pre-Treatment TARGET | Ticagrelor Oral Tablet - Pre-Treatment | SFJ Pharmaceuticals, Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ticagrelor Oral Tablet - Pre-Treatment CI watch — RSS
- Ticagrelor Oral Tablet - Pre-Treatment CI watch — Atom
- Ticagrelor Oral Tablet - Pre-Treatment CI watch — JSON
- Ticagrelor Oral Tablet - Pre-Treatment alone — RSS
Cite this brief
Drug Landscape (2026). Ticagrelor Oral Tablet - Pre-Treatment — Competitive Intelligence Brief. https://druglandscape.com/ci/ticagrelor-oral-tablet-pre-treatment. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab